Name | Type | Posted | Actions |
|---|---|---|---|
SOW.docx | DOCX | May 29, 2026 |
NEXT GENERATION SEQUENCING ITEMS
Contact and place of performance
Luciana Encinas
Bellavista, PE-CAL 07001
PER
The laboratory of the Virology Department of the U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH) is looking to purchase reagents to prepare libraries using human samples that later will be sequenced in the MiSeq and MiniSeq platforms developed by Illumina, as part of the projects of next-generation sequencing (NGS) that are being conducted at this command. The reagents are: FC-110-3001 PhiX Control v3, MS-1...
View moreThe Virology Department of the U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH) requires specific reagents for preparing libraries from human samples to support ongoing next-generation sequencing (NGS) projects. These items are intended for use with Illumina MiSeq and MiniSeq platforms and include PhiX Control v3, MiSeq Reagent Kit v3 (600-cycle), Nextera XT DNA Library Preparation Kits, Nextera XT Index Kits (Sets A and B), and MiniSeq High Output Reagent Kits (300-cycles). All materials must be delivered to the NAMRU SOUTH facility located in Bellavista, Callao, Peru.
The Department of the Navy’s Naval Medical Research Center is managing this procurement under solicitation number VEID260013_1301365570. This special notice is designated as an 8AN 8AN set-aside. The acquisition is classified under NAICS code 424210 for Drugs and Druggists' Sundries Merchant Wholesalers and PSC 6550 for IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS.
Responses for this requirement are due by June 13, 2026. Detailed specifications are provided in a single attachment titled SOW.docx, which was issued on May 29, 2026. Luciana Encinas is the designated point of contact for this notice.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.